Study Reports Possible Novel Method for Stopping Untreatable Pediatric Brain Cancer
Effective Treatment Options Lacking for Leading Killer of Kids with Cancer
Researchers used an experimental molecular therapy in preclinical laboratory tests to effectively treat several types of deadly pediatric brain cancer and now propose advancing the treatment to clinical testing in children.
Scientists at the Cincinnati Children’s Cancer and Blood Diseases Institute report testing the small molecule 6-thio-2’deoxyguanosine (6-thio-dG) in brain cancer stem cells derived from tumor cells donated by patients. Researchers also tested the treatment in humanized mouse models of pediatric brain cancer.
The cancers include intrinsic pontine glioma (DIPG), high-grade glioma (HGG) and high-risk medulloblastoma (MB).
Click here to read more.
2019 AANS/CNS Section on Pediatric Neurological Surgery Annual Meeting
Dec. 5-8, 2019; Scottsdale, Ariz.
Dec. 5-8, 2019; Mumbai, India
7th Emirates International Neurosurgical Conference
Dec. 12-14, 2019; Dubai, United Arab Emirates